- Home
- RAVE vs DXR Comparison
RAVE vs DXR Comparison
Compare RAVE & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAVE
- DXR
- Stock Information
- Founded
- RAVE 1958
- DXR 1970
- Country
- RAVE United States
- DXR United States
- Employees
- RAVE N/A
- DXR N/A
- Industry
- RAVE Restaurants
- DXR Medical/Dental Instruments
- Sector
- RAVE Consumer Discretionary
- DXR Health Care
- Exchange
- RAVE Nasdaq
- DXR Nasdaq
- Market Cap
- RAVE 39.1M
- DXR 36.4M
- IPO Year
- RAVE N/A
- DXR N/A
- Fundamental
- Price
- RAVE $2.70
- DXR $9.00
- Analyst Decision
- RAVE
- DXR Strong Buy
- Analyst Count
- RAVE 0
- DXR 1
- Target Price
- RAVE N/A
- DXR $25.00
- AVG Volume (30 Days)
- RAVE 23.7K
- DXR 5.7K
- Earning Date
- RAVE 05-08-2025
- DXR 01-01-0001
- Dividend Yield
- RAVE N/A
- DXR N/A
- EPS Growth
- RAVE 25.31
- DXR 86.16
- EPS
- RAVE 0.19
- DXR 0.11
- Revenue
- RAVE $12,240,000.00
- DXR $119,714.00
- Revenue This Year
- RAVE N/A
- DXR N/A
- Revenue Next Year
- RAVE N/A
- DXR N/A
- P/E Ratio
- RAVE $14.73
- DXR $86.02
- Revenue Growth
- RAVE 3.35
- DXR N/A
- 52 Week Low
- RAVE $1.70
- DXR $6.55
- 52 Week High
- RAVE $3.36
- DXR $10.00
- Technical
- Relative Strength Index (RSI)
- RAVE 54.33
- DXR 52.74
- Support Level
- RAVE $2.63
- DXR $8.75
- Resistance Level
- RAVE $2.83
- DXR $9.90
- Average True Range (ATR)
- RAVE 0.13
- DXR 0.39
- MACD
- RAVE -0.01
- DXR -0.08
- Stochastic Oscillator
- RAVE 42.89
- DXR 52.17
About RAVE Rave Restaurant Group Inc.
Rave Restaurant Group Inc operates and franchises pizza buffet, delivery/carry-out, express restaurants, and ghost kitchens. It operates restaurants under the brand name, Pizza Inn, and Pie Five Pizza Company. It has three operating segments. The Pizza Inn and Pie Five Franchising segments establish franchisees, licensees, and territorial rights. The company-owned restaurant segment includes sales and operating results for all company-owned restaurants. The Pizza Inn Franchising segment accounts for the company's revenue. Geographically, it generates the majority of the revenue from the United States.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.